Exact Mass: 385.1671

Exact Mass Matches: 385.1671

Found 78 metabolites which its exact mass value is equals to given mass value 385.1671, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(R)-N-(1-Methyl-2-phenylethyl)adenosine

2-Hydroxymethyl-5-[6-(1-methyl-2-phenyl-ethylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol

C19H23N5O4 (385.175)


D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents

   

Isopropylphenyladenosine

2-(hydroxymethyl)-5-{6-[phenyl(propan-2-yl)amino]-9H-purin-9-yl}oxolane-3,4-diol

C19H23N5O4 (385.175)


   

Minoxidil Glucuronide

6-{[6-amino-2-imino-4-(piperidin-1-yl)-1,2-dihydropyrimidin-1-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H23N5O7 (385.1597)


   

n6-phenylisopropyladenosine

5-(hydroxymethyl)-2-[6-(phenylamino)-9H-purin-9-yl]-2-(propan-2-yl)oxolane-3,4-diol

C19H23N5O4 (385.175)


   

31F508b1

Antibiotic 31F508b1

C20H23N3O5 (385.1638)


   

Amisulpride N-Oxide

Amisulpride N-Oxide

C17H27N3O5S (385.1671)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3399 CONFIDENCE standard compound; INTERNAL_ID 2143

   

MAM-2201 N-pentanoic acid metabolite

MAM-2201 N-pentanoic acid metabolite

C25H23NO3 (385.1678)


   

5-Benzyl-N-Dimethyladenosine

5-Benzyl-N-Dimethyladenosine

C19H23N5O4 (385.175)


   

N2-(N2-L-Pyroglutamyl-L-glutaminyl)-L-glutamin|N2-(N2-L-pyroglutamyl-L-glutaminyl)-L-glutamine

N2-(N2-L-Pyroglutamyl-L-glutaminyl)-L-glutamin|N2-(N2-L-pyroglutamyl-L-glutaminyl)-L-glutamine

C15H23N5O7 (385.1597)


   

methyl 7-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-L-glycero-alpha-D-manno-heptopyranoside

methyl 7-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-L-glycero-alpha-D-manno-heptopyranoside

C14H27NO11 (385.1584)


   

2-acetamido-2-deoxy-3-O-(beta-D-galactopyranosyl)-D-galactitol|2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-galactitol|beta-D-Gal-(1->3)-D-GalNAcol|beta-D-Galp(1->3)-D-GalNAc-ol|beta-Gal-(1-3)-GalNAc-ol

2-acetamido-2-deoxy-3-O-(beta-D-galactopyranosyl)-D-galactitol|2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-galactitol|beta-D-Gal-(1->3)-D-GalNAcol|beta-D-Galp(1->3)-D-GalNAc-ol|beta-Gal-(1-3)-GalNAc-ol

C14H27NO11 (385.1584)


   
   
   
   

H-GLY-PHE-TYR-OH

H-GLY-PHE-TYR-OH

C20H23N3O5 (385.1638)


   
   
   
   
   
   
   
   

minoxidil glucuronide

Minoxidil-O-glucuronide

C15H23N5O7 (385.1597)


   
   
   
   
   

(R)?-?PIA

(R)-N-(1-Methyl-2-phenylethyl)adenosine

C19H23N5O4 (385.175)


D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents

   

fast black salt G

fast black salt G

C21H19N7O++ (385.1651)


   

Valethamate Bromide

Valethamate Bromide

C19H32BrNO2 (385.1616)


   

3-{isopropyl[(Trans-4-Methylcyclohexyl)carbonyl]amino}-5-Phenylthiophene-2-Carboxylic Acid

3-{isopropyl[(Trans-4-Methylcyclohexyl)carbonyl]amino}-5-Phenylthiophene-2-Carboxylic Acid

C22H27NO3S (385.1712)


   

2-Acetamido-2-deoxyglucosylgalactitol

2-Acetamido-2-deoxyglucosylgalactitol

C14H27NO11 (385.1584)


   

(4as)-5-[(2,4-Diaminopteridin-6-Yl)methyl]-4a,5-Dihydro-2h-Dibenzo[b,F]azepin-8-Ol

(4as)-5-[(2,4-Diaminopteridin-6-Yl)methyl]-4a,5-Dihydro-2h-Dibenzo[b,F]azepin-8-Ol

C21H19N7O (385.1651)


   

[N-(3-Dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid

[N-(3-Dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid

C20H23N3O5 (385.1638)


   
   

1-[1-[2-(4-Methoxyphenyl)ethyl]-2,5-dimethyl-3-pyrrolyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanone

1-[1-[2-(4-Methoxyphenyl)ethyl]-2,5-dimethyl-3-pyrrolyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanone

C19H23N5O2S (385.1572)


   

Galbeta1-3GalNAc-ol

Galbeta1-3GalNAc-ol

C14H27NO11 (385.1584)


   
   
   
   
   
   

Galbeta1-4GlcNAc-ol

Galbeta1-4GlcNAc-ol

C14H27NO11 (385.1584)


   

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)


   

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)


   

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)


   

N-[(2R,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

N-[(2R,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)


   

N-[(2R,3R,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

N-[(2R,3R,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)


   

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)


   

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)


   

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide

C17H27N3O5S (385.1671)


   

N-[(2S,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

N-[(2S,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)


   

N-[(2S,3S,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

N-[(2S,3S,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)


   

N-[(2S,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

N-[(2S,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)


   

N-[(2R,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

N-[(2R,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide

C17H27N3O5S (385.1671)


   

2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-glucitol

2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-glucitol

C14H27NO11 (385.1584)


   

jacoline N-oxide

jacoline N-oxide

C18H27NO8 (385.1737)


A pyrrolizine alkaloid that is jacoline in which the tertiary amino function has been oxidised to the corresponding N-oxide.

   
   
   
   
   
   

2-aminoethyl 4-O-beta-D-glucopyranosyl-alpha-D-glucopyranoside

2-aminoethyl 4-O-beta-D-glucopyranosyl-alpha-D-glucopyranoside

C14H27NO11 (385.1584)


   

Galalpha1-3GalNAc-ol

Galalpha1-3GalNAc-ol

C14H27NO11 (385.1584)


   

2-acetamido-2-deoxy-3-O-D-galactopyranosyl-D-galactitol

2-acetamido-2-deoxy-3-O-D-galactopyranosyl-D-galactitol

C14H27NO11 (385.1584)


   

N-[(2S,3R,4R,5R)-1,3,5,6-Tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide

N-[(2S,3R,4R,5R)-1,3,5,6-Tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide

C14H27NO11 (385.1584)


   

N-[(2S,3R,4S,5R)-1,3,4,5-Tetrahydroxy-6-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide

N-[(2S,3R,4S,5R)-1,3,4,5-Tetrahydroxy-6-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide

C14H27NO11 (385.1584)


   

2-aminoethyl 4-O-alpha-D-glucopyranosyl-alpha-D-galactopyranoside

2-aminoethyl 4-O-alpha-D-glucopyranosyl-alpha-D-galactopyranoside

C14H27NO11 (385.1584)


   

2-Hydroxymethyl-5-[6-(1-methyl-2-phenyl-ethylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol

2-Hydroxymethyl-5-[6-(1-methyl-2-phenyl-ethylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol

C19H23N5O4 (385.175)


D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents

   
   

n-{4-[(4s)-2-(2,3-dihydroxyphenyl)-4,5-dihydro-3h-imidazol-4-yl]butyl}-2,3-dihydroxybenzenecarboximidic acid

n-{4-[(4s)-2-(2,3-dihydroxyphenyl)-4,5-dihydro-3h-imidazol-4-yl]butyl}-2,3-dihydroxybenzenecarboximidic acid

C20H23N3O5 (385.1638)


   

(19s,21s)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione

(19s,21s)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione

C20H23N3O5 (385.1638)


   

2-(2-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl)-6-methoxyoxane-3,4,5-triol

2-(2-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl)-6-methoxyoxane-3,4,5-triol

C14H27NO11 (385.1584)


   

(1r,3r,6r,13r,18r,19s,21s,23r)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione

(1r,3r,6r,13r,18r,19s,21s,23r)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione

C20H23N3O5 (385.1638)


   

9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione

9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione

C20H23N3O5 (385.1638)


   

n-{4-[2-(2,3-dihydroxyphenyl)-4,5-dihydro-3h-imidazol-4-yl]butyl}-2,3-dihydroxybenzenecarboximidic acid

n-{4-[2-(2,3-dihydroxyphenyl)-4,5-dihydro-3h-imidazol-4-yl]butyl}-2,3-dihydroxybenzenecarboximidic acid

C20H23N3O5 (385.1638)


   

(2r,3s,4s,5s,6s)-2-[(1s)-2-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl]-6-methoxyoxane-3,4,5-triol

(2r,3s,4s,5s,6s)-2-[(1s)-2-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl]-6-methoxyoxane-3,4,5-triol

C14H27NO11 (385.1584)